Candel Therapeutics, Inc.
CADL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001841387
In the last 90 days, Candel Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 137 institutions reported holding it in 13F filings for Q2 2026, worth $518.9M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Candel Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 12
- +12 vs. Q2 2021
- Shares held
- 4.88M
- +4.88M vs. Q2 2021
- Total value
- $52.9M
- +$52.9M vs. Q2 2021
- New holders
- 12
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CADL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 137 | $518.9M |
| Q1 2026 | 114 | $212.9M |
| Q4 2025 | 84 | $133.5M |
| Q3 2025 | 81 | $115.6M |
| Q2 2025 | 78 | $116.6M |
| Q1 2025 | 82 | $119.7M |
| Q4 2024 | 71 | $155.7M |
| Q3 2024 | 52 | $46.4M |
| Q2 2024 | 45 | $37.0M |
| Q1 2024 | 20 | $5.97M |
| Q4 2023 | 22 | $5.92M |
| Q3 2023 | 20 | $4.86M |
| Q2 2023 | 20 | $6.77M |
| Q1 2023 | 21 | $7.44M |
| Q4 2022 | 21 | $9.70M |
| Q3 2022 | 25 | $19.1M |
| Q2 2022 | 23 | $20.6M |
| Q1 2022 | 23 | $34.0M |
| Q4 2021 | 20 | $54.4M |
| Q3 2021 | 12 | $52.9M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Candel Therapeutics, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 2,500,000 | $27.1M | 0.00% | +2,500,000 | New |
| Franklin Resources Inc | 1,125,000 | $12.2M | 0.00% | +1,125,000 | New |
| Sands Capital Ventures, LLC | 811,737 | $8.80M | 1.33% | +811,737 | New |
| Vanguard Group Inc | 213,580 | $2.31M | 0.00% | +213,580 | New |
| Woodline Partners LP | 100,000 | $1.08M | 0.02% | +100,000 | New |
| Caas Capital Management LP | 50,000 | $542.0K | 0.04% | +50,000 | New |
| State Street Corp | 26,600 | $288.0K | 0.00% | +26,600 | New |
| BlackRock Inc. | 22,326 | $242.0K | 0.00% | +22,326 | New |
| Geode Capital Management, LLC | 20,395 | $221.0K | 0.00% | +20,395 | New |
| Millennium Management LLC | 10,646 | $115.0K | 0.00% | +10,646 | New |
| UBS Group AG | 3,000 | $33.0K | 0.00% | +3,000 | New |
| Wells Fargo & Company | 1,054 | $12.0K | 0.00% | +1,054 | New |